Castle Biosciences (CSTL) Other Working Capital Changes (2018 - 2026)

Castle Biosciences has disclosed Other Working Capital Changes across 9 years of filings, most recently posting $530000.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $530000.0, down 84.24% year-over-year; the trailing twelve-month figure through Mar 2026 was -$2.5 million (down 185.93% YoY), and the FY2025 annual result was $366000.0, up 239.69% from the prior year.
• Other Working Capital Changes came in at $530000.0 for Q1 2026 at Castle Biosciences, up from -$4.2 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $5.4 million in Q3 2025 to a low of -$4.2 million in Q2 2025.
• The 5-year median for Other Working Capital Changes is $148000.0 (2023), against an average of $51647.1.
• Across the five-year window, Other Working Capital Changes plunged 4752.5% in 2024 and soared 1362.61% in 2025, its largest moves.
• Castle Biosciences' Other Working Capital Changes stood at -$2.5 million in 2022, then surged by 98.39% to -$40000.0 in 2023, then slumped by 4752.5% to -$1.9 million in 2024, then slumped by 114.79% to -$4.2 million in 2025, then jumped by 112.71% to $530000.0 in 2026.
• The last three Other Working Capital Changes figures came in at $530000.0 (Q1 2026), -$4.2 million (Q4 2025), and $5.4 million (Q3 2025), per Business Quant data.